[Federal Register Volume 61, Number 137 (Tuesday, July 16, 1996)]
[Notices]
[Page 37081]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-18023]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 26, 1996, and published in the Federal 
Register on March 4, 1996, (61 FR 8303), MD Pharmaceutical, Inc., 3501 
West Garry Avenue, Santa Ana, California 92704, made application to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                            Drug                               Schedule 
------------------------------------------------------------------------
Methylphenidate (1724)......................................         II 
Diphenoxylate (9170)........................................         II 
------------------------------------------------------------------------

    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
MD Pharmaceutical, Inc. to manufacture the listed controlled substances 
is consistent with the public interest at this time. Therefore, 
pursuant to 21 U.S.C. 823 and 28 C.F.R. 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
above is granted.


    Dated: July 3, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-18023 Filed 7-15-96; 8:45 am]
BILLING CODE 4410-09-M